Correlation between DNA methylation status of Fgf21 and FGF21 expression. a, b Hepatic Fgf21 mRNA expression and serum FGF21 concentrations in Wy- and DMSO (Veh)-treated offspring from D2 to 14W. The gray-shaded box indicates the period of maternal administration of Wy or Veh (n = 8 per group). c Hepatic Fgf21 mRNA expression after a single Wy injection in Wy- and Veh-offspring at 14W (left, n = 5–8 per group). Correlation between Fgf21 mRNA expression and DNA methylation (right, n = 13). d Serum FGF21 concentrations after a single Wy injection in Wy- and Veh-offspring at 14W (left, n = 4–7 per group). Correlation between serum FGF21 concentrations and DNA methylation (right, n = 11). e Serum FGF21 concentrations during fasting and refeeding (left, n = 7–9 per group). Correlation between serum FGF21 concentrations after a 24-h fast and DNA methylation (right, n = 16). f Serum NEFA concentrations during fasting and refeeding (n = 7–9 per group). g, h ChIP assays for Pol II in Wy- and Veh-offspring at D16 (g) and with a single DMSO (Veh) or Wy injection at 14W (h). Primers amplifying the region of −106 to +21 bp were used for Pol II (Fig. ) (n = 7–8 per group). Statistics by unpaired Student’s t-test (a, b, c–e left, f, g, h) or Spearman’s rank correlation coefficient (c–e right). The r- and p-values are indicated on the graph. Data are expressed as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; N.S., not significant vs. Veh-offspring